The timeline for CD12 results presented certainly seems reasonable. There are two problems at the present, however. First, a company with a trial in the same space, RLFTF, completed their trial after us and announced TLD over a week ago. You could argue that bad results needed to be disclosed and are easy to compile, but either way they turned theirs around much quicker than we did, and it's not like they are flush with cash either. Secondly, our CEO publicly stated three weeks ago that the data would be locked "next week". By now, most of us know that "Nader-time" is an entity unto itself. He's typically off by a factor of 3x longer than he says, and I was hoping he learned from his previous 50 predicted timeline misses.

Quote:

---

Great summary on CD-12 timeline expectations by "Hulk" on the Yahoo board:

"Just want to share some industry knowledge regarding timelines after speaking with a trial statistician who leads trial design in multiple pharmaceutical companies.

Basically three milestones after LPLV (last patient last visit). LPLV for CD10 is 14 days after enrollment and CD12 is 28 days after full enrollment.

1. Database Lock - 6 weeks. This involves all the verification that needs to happen for every patient and signed off by all sites. Once data is locked, nobody can change anything related to raw data.

2. Data unblinding - 1 week. This step could be faster if everything goes as planned but typically targeted for a week allow some wiggle room.

3. Top line report - 1 week.

Read More: https://investorshangout.com/post/newpost/605...z6mpncWoaf

---